Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update

Source :: GlobeNewswire. May 14, 2024
Publication Year :: 2024
Abstract: Vivos Expanding its Revenue Generating Initiatives As Operating Expenses Decrease 22%, Representing Seven Consecutive Quarters of Year Over Year Improvement Due to Successful Cost Cutting Initiatives Management to Host Conference [...]

Subjects :: High technology industry
Sleep apnea syndromes -- Care and treatment
Company earnings/profit
Banking, finance and accounting industries
Business

Tools